Remifentanil Hydrochloride
Product Images NDC 75834-232

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Remifentanil Hydrochloride (NDC 75834-232). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of Remifentanil hydrochloride showing the molecular arrangement including ester and amide functional groups, a cyclohexyl ring, and a phenyl ring attached to the nitrogen group.*

FDA Label Image

Figure-1 (Figure 1)

Line graph comparing minute ventilation percentage of baseline over time (in minutes) for Remifentanil Hydrochloride for injection and Alfentanil. The x-axis represents time with periods during infusion and post infusion separated. The y-axis shows minute ventilation as a percentage of baseline. Data includes error bars and sample sizes (n=11 for Remifentanil Hydrochloride and n=10 for Alfentanil).*

FDA Label Image

Figure-2 (Figure 2)

A line graph comparing mean concentration over time (minutes) of Alfentanil and Remifentanil Hydrochloride for injection. The y-axis shows mean concentration in ng/mL on a logarithmic scale, and the x-axis shows time in minutes. Alfentanil is administered at 0.5 mcg/kg/min (n=5), and Remifentanil at 0.05 mcg/kg/min (n=6), with error bars representing standard deviation.*

FDA Label Image

Container Label-1mg Per Vial (Container Label 1mg Per Vial)

Label for Remifentanil Hydrochloride for Injection 1 mg per vial, a sterile single-dose vial intended for intravenous use only. The label notes prescription use, instructions to reconstitute and dilute before use, and to discard any unused portion. Manufactured for Nivagen Pharmaceuticals, Inc., Sacramento, CA.*

FDA Label Image

Container-label-2mg-per-vial (Container Label 2mg Per Vial)

Remifentanil Hydrochloride for Injection 2 mg per vial sterile single-dose vial label for intravenous use only. Manufactured for Nivagen Pharmaceuticals, Inc., Sacramento, CA. The label includes instructions to reconstitute and dilute before use and discard unused portions. Features space for barcode, batch number, and expiration date.*

FDA Label Image

Container-label-5mg-per-vial (Container Label 5mg Per Vial)

Label for Remifentanil Hydrochloride for Injection, 5 mg per vial, a single-dose vial for intravenous use only. The label includes instructions to reconstitute and dilute before use, with a note to see the insert for usual dosage. Manufactured for Nivagen Pharmaceuticals, Inc., Sacramento, CA, with revision date 02/2022. Contains a space for batch number, expiration date, and a barcode placeholder.*

FDA Label Image

Carton-label-1mg-per-vial (Carton Label 1mg Per Vial)

Packaging label for Remifentanil Hydrochloride for Injection 1 mg per vial by Nivagen Pharmaceuticals, Inc. The label indicates the product is for intravenous use only and contains ten 1 mg single-dose vials. It includes storage instructions, dilution and administration guidance, NDC number 75834-230-10, and manufacturer contact details. The label features a non-varnish area with GTIN and lot/expiration placeholders and a space for a barcode.*

FDA Label Image

Carton-label-2mg-per-vial (Carton Label 2mg Per Vial)

Packaging label for Remifentanil Hydrochloride for Injection, 2 mg per vial, equivalent to 2 mg of remifentanil. The label indicates it is for intravenous use only and contains 10 single-dose vials of 2 mg each. Manufactured by Nivagen Pharmaceuticals, Inc., the label includes storage instructions, dosing preparation information, and a barcode area.*

FDA Label Image

Carton-label-5mg-per-vial (Carton Label 5mg Per Vial)

Remifentanil Hydrochloride for Injection 5 mg per vial packaging label from Nivagen Pharmaceuticals, Inc. The label indicates the product is for intravenous use only and contains 10 single-dose vials each with 5 mg of remifentanil equivalent. Instructions include discarding unused portions and reconstitution details. The label also includes storage information and manufacturer contact details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.